FDA approves at-home flu vaccine
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
A flu vaccine you can administer yourself, stroke deaths on the rise and drug overdose deaths decreasing: Here's what happened in health this week.
Tomorrow is the first day of fall; kick off cozy season with some tasty fall produce (it’s good for you!). And now, here’s ...
FDA approves first flu vaccine that can be self-administered at home
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
kalkinemedia20h
AstraZeneca (AZN) Experiences Notable Market Shift: Key Insights
Key Insights ...
devdiscourse2h
Major Updates in Health: Drug Approvals, Legal Battles, and Health Innovations
Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...
EuropaWire12h
FluMist Becomes First At-Home Self-Administered Flu Vaccine Approved by FDA
FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...
No doctor necessary: U.S. okays nasal spray flu vaccine for self-use
FDA approves FluMist nasal spray flu vaccine for self-administration, available online for Americans, increasing convenience ...
The Pharma Letter9h
FluMist approved for self-administration in the USA
On Friday, the US Food and Drug Administration approved UK pharma major AstraZeneca’s (LSE: AZN) FluMist for self- or ...
Daily16h
AstraZeneca FluMist gets USFDA nod for self-administered influenza vaccine
AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...
devdiscourse15h
Latest Health Developments: Key Approvals and Controversies
Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...
FDA approves first self-administered flu vaccine
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...